We describe here the de®nition and characterization of antigen CT-8/HOM-TES-85 encoded by a previously unknown gene and identi®ed by serological expression screening using antibodies from a seminoma patient. Intriguingly, the leucine zipper region of CT-8/HOM-TES-85 shows an atypical amphipathy with clusters of hydrophobic residues that is exclusively shared by the Nmyc proto-oncogene. CT-8/HOM-TES-85 gene is tightly silenced in normal tissues except for testis. However, it is frequently activated in human neoplasms of dierent types including lung cancer, ovarian cancer, melanoma and glioma. Endogenous as well as heterogeneously expressed CT-8/HOM-TES-85 targets predominantly to the nucleus forming a distinctive speckled pattern of nuclear dots arranged in macromolecular structures. By co-localization studies these speckles were identi®ed as loci of transcriptional activity and splicing, suggesting that CT-8/HOM-TES-85 may be involved in these processes. The aberrant expression of CT-8/HOM-TES-85 in human neoplasms might therefore be involved in cancer associated alterations of transcriptional or post-transcriptional processes and thus may disclose new mechanisms involved in the manifestation of the cancer phenotype.
Introduction
The development of cloning strategies for the systematic identi®cation of cancer derived gene products recognized speci®cally by the cellular or humoral immune system of the tumour bearing host resulted in the identi®cation of multiple tumour antigens in the last decade (Boon and Old, 1997; . The primary intention was to identify new potential targets for immunotherapeutical interventions, unravelling the target structures of spontaneously occurring immunorecognition of tumours. However, this did not only open new avenues for speci®c cancer immunotherapy, but also provided unexpected insights into cancer related genotypic and phenotypic alterations (Disis and Cheever, 1996; Wang et al., 1999) . Immunogenic alterations in cancer associated gene products have potentially an impact on the pathogenesis or progression of cancer. This is evident for antigens encoded by known oncogenes, i.e. ampli®ed and/or overexpressed Her2/neu, c-myc or mutated p53. However, for several proteins identi®ed due to underlying immunogenic mutations the biological signi®cance of the respective mutations was disclosed subsequent to their initial discovery as antigens. One example is a melanoma associated mutation of cyclin dependent kinase CDK4, which prevents the protein from binding to its inhibitor, the cell cycle regulator p16, resulting in uncontrolled growth of cells harbouring this mutation (WoÈ lfel et al., 1995) . Other examples are the Ser 47 mutation of b-catenin gene leading to a more stable gene product interacting with the transcription factors Lef and TCF (Rubinfeld et al., 1997) and a mutation of the CASP-8 gene detected in lung cancer associated with a reduced pro-apoptotic activity of the protein (Mandruzzato et al., 1997) .
Little is known about the biological signi®cance of unmodi®ed gene products which are ectopically expressed in cancer cells. Examples for this are members of the cancer/testis (CT) or cancer germ line gene class, which are not expressed in other normal tissues except for spermatogonia but ectopically in a variety of human cancers (Chen and Old, 1999) . The physiological function of most CT gene products is unknown. Exceptions are HOM-TES-14/SCP-1, which is involved in meiotic chromosome pairing Meuwissen et al., 1997) , and the SSX genes, containing a KRAB domain that has recently been shown to have a transcriptional repressor function Lim et al., 1998) .
For the systematic and unbiased cloning of tumour antigens recognized by the antibody repertoire of cancer patients we recently developed the SEREX approach (Sahin et al., 1995) . SEREX is based on the screening of tumour-derived expression libraries with autologous patient sera. Applying SEREX to a range of tumour types, a multitude of novel cancer-associated immunogenic gene products has been identi®ed EichmuÈ ller et al., 2001; GuÈ re et al., 2000; Ono et al., 2001) . Many of the identi®ed antigens are encoded by hitherto unknown genes with unknown functions . We describe here the identi®cation and characterization of a novel member of the CT antigen to class HOM-TES-85, with no signi®cant homology proteins, but structural peculiarities shared exclusively by the N-myc oncoprotein. On the basis of computational sequence motif analysis and subcellular localization studies of endogenous as well as heterologeously expressed protein, we provide evidence that HOM-TES-85 may be involved in cancer related transcriptional or post-transcriptional processes. According to the nomenclature proposed by Old and Chen (1998) we designated the gene product represented by clone HOM-TES-85 as CT-8.
Results

Detection of reactive clones and preliminary characterization
Two hundred thousand clones were screened with 1 : 200 diluted serum from a seminoma patient. Nine primary positive clones were found representing six dierent transcripts (Table 1) . New gene products were submitted to GenBank. Assessment of sequence, expression pattern and serology as summarized in Table 1 identi®ed clone HOM-TES-85 as representing a new gene product with a restricted expression pattern and tumour restricted immunogenecity, so that it was chosen for further characterization.
Sequence analysis of HOM-TES-85
The 1717 bp cDNA insert of clone HOM-TES-85 presented an N-terminal methionine complying with the general features of a translation initiation site, followed by a 942 bp ORF encoding a 314 aa protein with a predicted molecular weight of 39.5 kDa, and by a long 3'-UTR containing a typical polyadenylation signal ( Figure 1a ). Sequence comparison with public databases did not yield any identity or homology matches at the nucleic acid or protein levels. The carboxy-terminal part of the predicted protein (aa 160 ± 288) was composed of a total of 19 sequentially aligned repeats of heptads. The proximal 11 repeats (aa 166 ± 236) followed the same consensus motif (-HGHSERS-), whereas the following eight repeats (aa 237 ± 291) share a dierent consensus motif (-QRDLIAT-), notably representing an unusually long leucine zipper ( Figure  1a) . Modelling of the leucine zipper region in a helical wheel diagram revealed an atypical amphipathy with clusters of hydrophobic residues appearing at positions a, b and c of the helix (Figure 1b) . Thus the helix exposes hydrophobic surfaces to all directions. Screening all proteins of the SWISSPROT database for this particular structural feature disclosed the N-myc protooncogene as only hit. Conformational analysis using several algorithms (Garnier et al., 1996; Geourjon and Deleage, 1995; Deleage and Roux, 1987 ) revealed a high probability for a-helical structures in the leucine zipper region as well as at the N-terminus in a region with prevailing basic amino acids. Screening for signal sequences and compartmentalization motifs using the pSORT tool (Nakai and Horton, 1999 ) disclosed a 65% armative prediction for nuclear localization of the gene product.
Genomic structure of HOM-TES-85
BlastN 2.1.2 database alignment of CT-8/HOM-TES-85 cDNA sequence to human genome sequences revealed identity to a unique 17 kb sequence region on chromosome Xq23-24 (accession number HSJ237H22).
Expression of CT-8/HOM-TES-85
The expression of HOM-TES-85 in normal tissues and tumour specimens was analysed by RT ± PCR ( Figure  2 ) as well as by Northern blot hybridization (Figure 3) . No expression was detectable in any healthy adult tissue, except for testis (Table 2 ). PBMCs do not express HOM-TES-85 even upon activation indicating that HOM-TES-85 does not represent a physiological proliferation antigen. However, PBMC scored positive for HOM-TES-85 transcripts 48 h after induction of genomic hypomethylation with 5-aza-2'-desoxycytidine. Expression in tumour tissue was investigated by speci®c RT ± PCR of a large panel of tumour-derived ®rst-strand cDNAs, and for selected samples additionally by Northern blot (Figure 3 ). Primer pairs 293S/ 865AS and 293S/1480AS were used and yielded identical results. CT-8/HOM-TES-85 expression was detected in 7/22 ovarian cancers, in 4/13 seminomas, 2/ 21 colorectal tumours, 8/29 lung cancers, 8/22 malignant melanoma, 7/20 gliomas, 2/2 teratocarcinoma, and two melanoma cells lines by speci®c RT ± PCR (Table 2) . Northern blots revealed a transcript of 1.85 kb (Figure 3 ) compatible with the cloned fulllength sequence together with a poly(A)-tail. Based on this expression pro®le this gene product was named CT-8.
Screening of sera for circulating autoantibodies against CT-8/HOM-TES-85
In order to evaluate the prevalence of circulating anti-CT-8/HOM-TES-85 IgG autoantibodies, sera of paTumour-associated leucine zipper involved in transcription O È Tu Èreci et al tients and healthy controls were screened using the phage assay. One of seven patients with ovarian cancer and one additional patient out of 14 patients with seminoma (besides the one used for cloning) had a (Kim et al., 2000) [AF229438] HOM-TES-87 AF124431 Homologous to rat NUDE1 (nuclear Highly overexpressed in testis 0/10 healthy distribution gene E homologue) interacting shown by Northern blot, expression in 1/10 seminoma with the microtubule-associated and normal tissues detectable by RT ± PCR centrosomal LIS1 (Wynshaw-Boris and Gambello, 2001) [XM_027306] HOM-TES-88, 94, 95 AF124434 Identical to the plasmocytoma marker Ubiquitous by RT ± PCR, not 0/12 healthy PC326 (Bergsagel et al., 1992) 
Heterologeous expression of eGFP-tagged HOM-TES-85
We anticipated that the identi®cation of organelles and functional units that may require this protein might give clues to its function and activity. Since the generation of antibodies is time-consuming and labour-intensive, we decided to study cellular localization of eGFP-tagged HOM-TES-85 transfected into eucaryotic cell lines (CHO, A431, MCF7, SK-Mel37). We found that independent of N-terminal or Cterminal tagging with eGFP, HOM-TES-85 distribution shows the same immuno¯uorescence pattern, which is substantially dierent from cells transfected with eGFP alone, suggesting that the tag does not in¯uence compartimentalization of this protein. Immuno¯uorescence microscopy revealed the formation of speckles, which are con®ned to the nucleus and organized in small groups (Figure 4a ). To gain a better understanding of the supramolecular structures in which this protein obviously organized itself, immunostainings with well-characterized sera from patients diagnosed for autoimmune diseases and containing autoantibodies to centromers (Kallenberg, 1990) , U3-RNP/®brillarin (Ochs et al., 1985) , SP100 (Szostecki et al., 1987) , SS-A/Ro (McCaulie et al., 1989) , SS-B/La (Chan et al., 1989) and Coilin (Andrade et al., 1991) were performed. No signi®cant co-staining with eGFP-tagged CT-8/HOM-TES-85 was obtained with these sera. However, labelling with autoimmune sera speci®c for U1-snRNP (Venrooij and Sillekens, 1989) resulted in signi®cant co-localization (Figure 4b ). Presence of CT-8/HOM-TES-85 in these speckles was con®rmed by co-localization with SC-35 (Wang et al., 1991) , a component of the spliceosome (Figure 4c ). To con®rm our observations a polyclonal antibody was generated by immunizing a rabbit with recombinant CT-8/HOM-TES-85 protein. Antibody staining was performed on breast cancer cell line MDA-MB-435 expressing this gene product constitutively as assessed by RT ± PCR. Distribution of CT-8/HOM-TES-85 shows the same nuclear immuno¯uorescence pattern as observed for the heterologous eGFP-tagged protein ( Figure 5 ). Again a speckled pattern of dots was observed accumulating in regions with weak DAPIstaining representing low chromatin density and transcriptional activity. However, we found additionally a pronounced staining of the nuclear envelope, which was not observed with heterologeously expressed eGFP-tagged protein ( Figure 5 ).
Discussion
Among the new antigens identi®ed in this study, CT-8/HOM-TES-85 was chosen for a more detailed characterization as it ful®ls the criteria of a tumour associated antigen, being absent from healthy tissues (except for testis) but expressed in a wide range of dierent human neoplasms and eliciting tumour associated antibody responses. The expression pattern of CT-8/HOM-TES-85 is characteristic for genes of the cancer/testis (CT) (also annotated as cancer/germ line) class, to which proteins encoded by the MAGE (van der Bruggen et al., 1991; Gaugler et al., 1995) , BAGE (Boel et al., 1995) , SSX (TuÈ reci et al., 1996) , NY-ESO/LAGE (Lethe et al., 1998; Chen et al., 1997) gene families belong. These antigens have raised increasing attention as potential targets for vaccine therapies of cancer patients . DNA methylation as impaired by 5'-aza-2'-deoxycytidine treatment seems to be responsible for CT-8/HOM-TES-85 silencing in tissues as described previously for MAGE genes (De Smet et al., 1996 . Interestingly, electronical chromosome mapping located CT-8/HOM-TES-85 gene to the X-chromosome, which harbours most of the other CT genes previously described. As homology alignments in nucleic acid and protein databases did not disclose any signi®cant similarities to known genes or proteins we searched for structural motifs in CT-8/HOM-TES-85 amino acid sequence. The most prominent functional motif detected is a long leucine zipper stretch in the Cterminus of the protein. Intriguingly, when modelled in a helical wheel diagram the leucine zipper region of CT-8/HOM-TES-85 shows an atypical amphipathy with clusters of hydrophobic residues appearing at positions a, b and c of the helix. As a consequence, the helix exposes hydrophobic surfaces to all directions. Screening all proteins of the SWISSPROT database for this particular structural feature, it turned out to be exclusively shared by the N-myc proto-oncogene. Moreover, the conformational analysis of CT-8/ HOM-TES-85 with dierent algorithms strongly suggested the presence of an N-terminal helical structure. In fact, in DNA-binding leucine zipper molecules the zipper region is regularly located in the C-terminus and is responsible for mediating speci®c protein dimerization (Kouzarides and Zi, 1988; Gentz et al., 1989; Turner and Tjian, 1989 ), which in turn is an essential prerequisite for DNA-binding activity of an N-terminal basic region. The sequence analysis being suggestive for involvement of CT-8/ HOM-TES-85 in transcriptional processes, we wanted to focus our studies on the subcellular localization of this protein, which may also be indicative of functional properties of this molecule.
A frequently encountered challenge in gene discovery is the need for a time-and cost-ecient way for a ®rst functional evaluation of newly discovered gene products. We propose an approach, which may be considered as a streamlined strategy down-stream to SEREX in particular, but also for other high output cloning strategies in general. The initial assessment of the function is based on a stringent database assisted sequence analysis to identify functionally relevant sequence motifs together with determination of subcellular protein targeting. The use of compartment and Figure 5 Detection of endogenous CT-8/HOM-TES-85 protein in breast cancer cell line MDA-MB-435. A speci®c anity-puri®ed rabbit antiserum was used for staining of endogenous protein (red¯uorescence). Co-staining of cells with DAPI elucidates expression of this protein in hypodensic areas of the nucleus (merge). In addition to nuclear speckles, there is decoration of the nuclear envelope, which was not observed upon heterologeous transfection Tumour-associated leucine zipper involved in transcription O È Tu Èreci et al organelle speci®c antisera for co-localization studies allows to assign the protein to a functional system and provides the basis for further speci®c functional studies. For this aim, heterologeously expressed HOM-TES-85-eGFP fusion proteins were studied in dierent eucaryotic cell lines. In the majority of transfected cells the protein is localized to the nucleus as con®rmed by co-localization with DNA staining, forming a distinct speckled pattern of nuclear dots arranged in groups. This pattern together with slow mobility of individual dots as revealed by time lapse microscopy analysis of eGFP-tagged protein (data not shown) indicated that HOM-TES-85 may be associated with dynamic macromolecular nuclear structures. To identify the nature of these speckles we co-labelled a series of endogenous nuclear antigens using human autoimmune sera with de®ned speci®cities to nuclear organelles and macromolecular structures. Thereby, co-localization with centromers, PCNA, p80/coilin, SP100/PML positive nuclear dots, as well as U3-snRNP/Fibrillarin positive structures were excluded. However, HOM-TES-85 speckles did co-localize with U1-snRNP, a major subunit of the spliceosome. As a matter of fact, antisera to U1-snRNP not only detect spliceosomes and sites of splicing, they also detect sites of assembly, transport or storage of spliceosome components resulting in both diuse and speckled staining (Sleeman and Lamond, 1999) . CT-8/HOM-TES-85 localization was found to be restricted to the speckled staining areas of U1-snRNP clustering. This prompted us to carry out co-staining with a monoclonal antibody to SC-35 (Fu and Maniatis, 1990 ). This protein is known to result in a pattern of very pronounced speckles lacking diuse nucleoplasmic staining (Sleeman and Lamond, 1999) by speci®c decoration of spliceosomes. Co-localization of CT-8/HOM-TES-85 with this spliceosome protein was proved.
We further con®rmed that endogenous CT-8/HOM-TES-85 protein apparently expressed in signi®cant amounts in tumour cell lines show the same nucleoplasmic pattern. Recent studies using BrUTP immunolabelling provided clear evidence that U1-snRNP clusters and SC-35 positive speckles are not only associated with splicing regions but also represent nuclear compartments with high levels of gene transcription (Neugebauer and Roth, 1997; Wei et al., 1999) . This suggests that CT-8/HOM-TES-85 might be a new component of the spliceosome or alternatively part of the transcriptosome in tumour cells (Halle and Meisterernst, 1996) .
Even though the structural features of CT-8/HOM-TES-85 suggest a role in transcription, further studies focusing on the identi®cation of binding partners and DNA/RNA binding properties of this protein have to clarify this point. Since transcriptional and posttranscriptional events are dynamic processes the availability of eGFP-tagged protein in combination with time-lapse microscopy will assist further dissection of this protein's function. We expect, that such studies will also explain the two distinct localizations (nuclear envelope vs nucleoplasmatic speckles) of endogenous CT-8/HOM-TES-85. Aberrant expression of this protein in cancer cells may result in tumourassociated alteration in transcription and/or posttranscriptional processes. It will therefore be interesting to study the transcriptional alterations in cells as a consequence of heterologeous CT-8/HOM-TES-85 expression.
Materials and methods
Sera, tissues and cell lines
Sera, tumour tissues and normal tissues collected from autopsies were obtained during routine diagnostic or therapeutic procedures with approval of the local ethical review board. Peripheral blood mononuclear cells (PBMC) were from healthy blood bank donors by the standard Ficoll paque method (Pharmacia, Freiburg, Germany). For activation, PBMC were cultured in RPMI 1640 medium/10% foetal calf serum either on cell culture plates coated with anti-CD3 and anti-CD28 antibodies or supplemented with PMA or PHA for several days according to standard protocols. Proliferating PBMCs were cultured for 48 h with 10 mM 5-Aza-2'-deoxycytidine to induce genomic hypomethylation (Sigma, Deisenhofen, Germany).
Construction and screening of subtractive cDNA expression library
As described elsewhere (TuÈ reci et al., 1998), a modi®cation of the recently described suppression subtractive hybridization (SSH) technique (Diatchenko et al., 1996) was used. Based on the suppression subtractive hybridization PCR a pool of testis-speci®c cDNA fragments was prepared using 2 mg mRNA derived from two dierent testicular tissue specimens as a tester probe, while the driver cDNA probe was synthesized from mRNA derived from 10 healthy tissues (colon, stomach, brain, resting and activated peripheral blood mononuclear cells, skeletal muscle, liver, kidney, lung and skin). The pool of testis-speci®c cDNAs obtained by subtraction was used to capture their long counterparts from a conventional cDNA phagemid library (4.0610 6 primary clones) in lambda Zap Express (Stratagene, Heidelberg, Germany) derived from the same two testis samples. For capturing, single-stranded pBK-CMV phagemid DNA was extracted after in vivo mass excision of the conventional phage expression library using standard protocols and hybridized to the testis cDNA derived from the suppression PCR blotted onto nitrocellulose membranes (Schleicher and SchuÈ ll, Heidelberg, Germany). After hybridization the nitrocellulose membranes were washed and phagemid bound to immobilized cDNA were eluted. Double-stranded cDNA inserts were synthesized using thermo-stable polymerase from Pyrococcus furiosus (Stratagene) and¯anking vector-speci®c primers (Reverse, Universe), excised by restriction enzyme digestion from the phagemids and re-ligated into precut dephosphorylated lambda ZAP Express vector. The ligation product was packaged into lambda phage 1 particles and used for transfection and library ampli®cation.
A serum from a 31-year-old seminoma patient suering from seminoma (pT2N0M0) was diluted 1 : 500 to immunoscreen this library for clones reactive with IgG antibodies as described in detail previously (Sahin et al., 1995) .
Sequence analysis of identified antigens
Positive clones were monoclonalized and subjected to in vivo excision of pBK-CMV phagemids. The nucleotide sequence of cDNA inserts was determined using EXCEL cycle sequencing kit (Epicentre) on a Li-COR sequencer according to the manufacturer's instructions. Sequence alignments were performed with DNASIS (Pharmacia Biotech, Freiburg, Germany) and BLAST software on EMBL, GenBank and PROSITE databases.
Expression analysis by Northern blot and reverse transcription PCR
Northern blots were performed with RNA extracted from tumours and normal tissues using standard protocols as described elsewhere in detail (TuÈ reci et al., 1996) .
By speci®c RT ± PCR the pattern of tissue expression was studied in a panel of cDNAs from healthy lung, colon, muscle, PBL, liver, kidney, breast, spleen, testis tissues for all clones identi®ed and for CT-8/HOM-TES-85 additionally in a large panel of dierent human tumour types. Therefore, total cellular RNA was primed with random hexamer and dT(18) oligonucleotides and reverse-transcribed with Superscript II (Gibco). All oligodT-primed ®rst-strand cDNAs were tested with primers selected from the 5' region of p53 to test integrity. Presence of CT-8/HOM-TES-85 transcripts was checked with two sets of speci®c primer pairs from the 5' region, since the majority of the 3' part turned out to be represented by one single exon. Ampli®cation with 250-S (5'-gga gag gct act caa gat gca gaa gc-3') and 1480-AS (5'-gtt cag ctg ccc aaa gat aca tct acc-3') yielded a 1230 bp fragment, whereas 250-S and 865-AS (5'-ctg agt gac tat gag atc tct ctg agt-3') resulted in two fragments (615 bp and 429 bp) due to annealing of the 3'-oligonucleotide to a repetitive sequence in the CT-8/HOM-TES-85 cDNA. Both primers did not amplify fragments from genomic DNA, con®rming that they hybridized to dierent exons. In each experiment templateless negative control and testis cDNA as positive control were included.
Screening of sera
Phages from positive clones were mixed with wild-type phages of the cDNA library as internal negative controls at a ratio of 1 : 10. 1 : 200 diluted sera from allogeneic patients and healthy controls were tested on the presence of hightitered speci®c IgG using the phage immunoscreening assay (Sahin et al., 1995) .
To extend the analysis to a larger number of sera, a speci®c ELISA (enzyme linked immuno absorbent assay) was established. CT-8/HOM-TES-85 was cloned into pQE31 vector (Qiagen) for procaryotic expression and puri®cation of recombinant protein. The ELISA was performed as described (Stockert et al., 1998) with minor modi®cations. Brie¯y, 50 ml/well of a 1 mg/ml solution of recombinant and puri®ed CT-8/HOM-TES-85 protein in coating buer (15 mM Na 2 CO 3 , 30 mM NaHCO 3 , pH 9.6, with 0.02% NaN 3 ) was absorbed to Maxisorp microwell plates 1268 (Nunc, Roskilde, Denmark) overnight at 48C. Plates were washed with PBS and blocked for 2 h at 378C with 100 ml/ well of 2% BSA/PBS. After washing, 50 ml/well of serum dilutions in 2% BSA was added and incubated for 2 h at room temperature. Plates were washed and 50 ml/well diluted secondary antibody/2% BSA was added (Goat anti-human IgG-AP; Jackson Immuno research, West Grove, PA, USA) and incubated for 1 h at room temperature. Plates were washed again, incubated with 50 ml/well of substrate solution (4-Nitrophenyl phosphate disodiumsalt, Merck, Darmstadt, Germany) for 30 min at room temperature, and immediately read (Wallac Victor; Perkin Elmer Instruments, U È berlingen, Germany). Sera were tested in a dilution of 1 : 400. A positive reaction is de®ned as an OD value of a 1 : 400 diluted serum that exceeds the mean OD value of sera from CT-8/HOM-TES-85 seronegative donors by three standard deviations. As a reference sera from 12 donors being CT-8/HOM-TES-85 negative in the phage assay were used.
Generation of specific polyclonal antiserum and immunostaining of endogenous CT-8/HOM-TES-85
Full-length CT-8/HOM-TES-85 was cloned into pQE31 vector (Qiagen) for procaryotic expression and puri®cation of recombinant protein. Polyclonal rabbit antiserum was obtained from a custom antibody service (SeqLab, GoÈ ttingen, Germany) after four immunizations with 50 ± 100 mg of puri®ed recombinant protein. After anity puri®cation using immobilized recombinant CT-8/HOM-TES-85 protein, sera before and after immunization were tested by Western blot analysis for reactivity with recombinant CT-8/HOM-TES-85 and a control protein expressed and puri®ed in the same way. The polyclonal serum but not the pre-immune serum did react with CT-8/HOM-TES-85 protein, whereas reaction with the unrelated control protein was not observed.
Expression of eGFP (enhanced green fluorescent protein)-tagged CT-8/HOM-TES-85 in eucaryotic cells
HOM-TES-85 phagemid clone was used for PCR with HOM-TES-85-BamHI-S (5'-gga tcc ggg aag atg gct tcg ttt cg-3') and HOM-TES-85-BamHI-AS (5'-cat tgt tct gag gat cca gta gtt att g-3') introducing two BamHI sites to both ends of this cDNA. The ampli®ed fragment was cut with BamHI restriction enzyme and ligated into vectors pEGFP-C1 and pEGFP-N3 (Clontech, Heidelberg, Germany) to obtain Nterminal or a C-terminal tags of enhanced green¯uorescent protein as a reporter. CHO, A431, MCF7 and SK-MEL-37 cell lines were grown on coverslips in RPMI 1640/10% FCS and transfected with plasmid constructs using Fugene (Roche, Mannheim, Germany).
Analysis of heterologeously transfected and endogenous CT-8/HOM-TES-85 in eucaryotic cells
Transfected and constitutionally expressing cells were grown on cover slips. Transfected cells were analysed starting 6 h after transfection for up to 24 h. Cells were washed with ice cold PBS-buer and after ®xation with either ice-cold methanol or 2% paraformaldehyde/0.1% saponin/PBS. Localization of tagged CT-8/HOM-TES-85 was investigated by conventional immuno¯uorescence and laser scanning confocal microscopy. For co-localization studies of CT-8/HOM-TES-85 with known human autoantigens sera with antibody-speci®cities against centromers, U3-snRNP/®brillarin, SP100/PML, Ro/La antigen, Coilin and U1-snRNP were used. To this end, transfected cells were stained after permeabilizing ®xation with 2% paraformaldehyde/0.1% saponin/PBS with either 1 : 100 diluted human autoimmune sera in 0.025% saponin/PBS and subsequently with rabbit-derived rhodamine conjugated anti-human-immunoglobulin antibodies (Dakopatts) or with a monoclonal antibody to SC-35 diluted 1 : 400 (Sigma, Deisenhofen, Germany) followed by goat antimouse IgG conjugated to FITC. Endogenous CT-8/HOM-TES-85 was detected with a speci®c polyclonal rabbit antiserum using¯uorescence-tagged second antibody directed against rabbit IgG. Coverslips were mounted on slides in Slow-Fade (Molecular Probes) for microscopic examination.
